Andrades KM et al. |
Modulation of Candida albicans virulence by antirejection immunosuppressant drugs. |
2013 |
Transplantation |
pmid:23380869
|
Eason JD et al. |
Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy. |
2003 |
Transplantation |
pmid:12717237
|
Rodrigo E et al. |
Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development. |
2016 |
Transplantation |
pmid:26703349
|
Metcalfe SM and Richards FM |
Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. |
1990 |
Transplantation |
pmid:1691537
|
Drachenberg CB et al. |
Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. |
1999 |
Transplantation |
pmid:10459544
|
Manez R et al. |
Rejection and hepatitis in liver transplants. |
1994 |
Transplantation |
pmid:7517080
|
Cao W et al. |
Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis. Inhibition of basic fibroblast growth factor and platelet-derived growth factor action and antagonism of rapamycin by FK506. |
1995 |
Transplantation |
pmid:7532879
|
Shihab FS et al. |
Mechanism of fibrosis in experimental tacrolimus nephrotoxicity. |
1997 |
Transplantation |
pmid:9422427
|
Vu MD et al. |
Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat. |
1997 |
Transplantation |
pmid:9422432
|
Ferraris JR et al. |
Conversion from cyclosporine A to tacrolimus in pediatric kidney transplant recipients with chronic rejection: changes in the immune responses. |
2004 |
Transplantation |
pmid:15084930
|
Shapiro R et al. |
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. |
1999 |
Transplantation |
pmid:10628763
|
Larsen JL et al. |
Tacrolimus and sirolimus cause insulin resistance in normal sprague dawley rats. |
2006 |
Transplantation |
pmid:16926589
|
Selzner N et al. |
Conversion from cyclosporine to FK506 in adult liver transplant recipients: a combined North American and European experience. |
2001 |
Transplantation |
pmid:11579301
|
Newell KA et al. |
Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice. |
1997 |
Transplantation |
pmid:9381541
|
Petruzzo P et al. |
The International Registry on Hand and Composite Tissue Transplantation. |
2010 |
Transplantation |
pmid:21052038
|
de Graav GN et al. |
A Randomized Controlled Clinical Trial Comparing Belatacept With Tacrolimus After De Novo Kidney Transplantation. |
2017 |
Transplantation |
pmid:28403127
|
Grudé P et al. |
MDR1 gene expression in peripheral blood mononuclear cells after liver transplantation. |
2002 |
Transplantation |
pmid:12085008
|
Xu X et al. |
FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506. |
2002 |
Transplantation |
pmid:12085010
|
Tan HP et al. |
Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience. |
2004 |
Transplantation |
pmid:15591960
|
Pérgola PE et al. |
Kidney transplantation during the first trimester of pregnancy: immunosuppression with mycophenolate mofetil, tacrolimus, and prednisone. |
2001 |
Transplantation |
pmid:11349738
|
Sanchez EQ et al. |
Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up. |
2010 |
Transplantation |
pmid:20098288
|
Moreau C et al. |
Interaction between tacrolimus and omeprazole in a pediatric liver transplant recipient. |
2006 |
Transplantation |
pmid:16477241
|
Swinnen LJ et al. |
Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder. |
2008 |
Transplantation |
pmid:18645482
|
Sureshkumar KK and Chopra B |
In search of an optimal induction agent in kidney transplantation. |
2014 |
Transplantation |
pmid:24978038
|
Welberry Smith MP and Baker RJ |
The author's reply. |
2014 |
Transplantation |
pmid:24978039
|
Homma M et al. |
Effects of lansoprazole and rabeprazole on tacrolimus blood concentration: case of a renal transplant recipient with CYP2C19 gene mutation. |
2002 |
Transplantation |
pmid:11821750
|
Zaltzman JS |
A comparison of short-term exposure of once-daily extended release tacrolimus and twice-daily cyclosporine on renal function in healthy volunteers. |
2010 |
Transplantation |
pmid:21166111
|
Chen H et al. |
Compromised kidney graft rejection response in Vervet monkeys after withdrawal of immunosuppressants tacrolimus and sirolimus. |
2000 |
Transplantation |
pmid:10836361
|
Metcalfe S and Milner J |
Evidence that FK506 and rapamycin block T cell activation at different sites relative to early reversible phosphorylation involving the protein phosphatases PP1 and PP2A. |
1991 |
Transplantation |
pmid:1710844
|
Anil Kumar MS et al. |
Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy. |
2005 |
Transplantation |
pmid:16210969
|
van Boekel GA et al. |
Effect of mild diarrhea on tacrolimus exposure. |
2012 |
Transplantation |
pmid:22955188
|
Ellis D et al. |
Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy. |
2007 |
Transplantation |
pmid:17589338
|
Bayés B et al. |
Adiponectin and risk of new-onset diabetes mellitus after kidney transplantation. |
2004 |
Transplantation |
pmid:15257035
|
Webb NJ et al. |
Corticosteroid-free Kidney Transplantation Improves Growth: 2-Year Follow-up of the TWIST Randomized Controlled Trial. |
2015 |
Transplantation |
pmid:25539467
|
Gralla J and Wiseman AC |
The impact of IL2ra induction therapy in kidney transplantation using tacrolimus- and mycophenolate-based immunosuppression. |
2010 |
Transplantation |
pmid:20595929
|
Glotz D et al. |
Thymoglobulin induction and sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids. |
2010 |
Transplantation |
pmid:20386144
|
Opelz G and Döhler B |
Association of mismatches for HLA-DR with incidence of posttransplant hip fracture in kidney transplant recipients. |
2011 |
Transplantation |
pmid:21452411
|
Miura Y et al. |
Factors increasing quantitative interstitial fibrosis from 0 hr to 1 year in living kidney transplant patients receiving tacrolimus. |
2011 |
Transplantation |
pmid:21452412
|
Cezário ES et al. |
Gingival overgrowth in renal transplant subjects medicated with tacrolimus in the absence of calcium channel blockers. |
2008 |
Transplantation |
pmid:18212628
|
Rayar M et al. |
High Intrapatient Variability of Tacrolimus Exposure in the Early Period After Liver Transplantation Is Associated With Poorer Outcomes. |
2018 |
Transplantation |
pmid:29315140
|
Kuypers DR et al. |
Clinically relevant drug interaction between voriconazole and tacrolimus in a primary renal allograft recipient. |
2006 |
Transplantation |
pmid:16794545
|
Scheel AK et al. |
Severe neurotoxicity of tacrolimus (FK506) after renal transplantation: two case reports. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750573
|
Jain AB et al. |
FK 506 dosage in human organ transplantation. |
1990 |
Transplant. Proc. |
pmid:1689890
|
Morris-Stiff G et al. |
Prospective randomized study comparing FK 506 (Prograft) and cyclosporine A (Neoral) as primary immunosuppression in cadaveric renal transplants at a single institution: interim report of the first 80 cases. |
1998 |
Transplant. Proc. |
pmid:9636525
|
Barrera-Pulido L et al. |
Switching from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients with gastrointestinal complications. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715870
|
Burke GW et al. |
Cholesterol control: long-term benefit of pancreas-kidney transplantation with FK 506 immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9532153
|
Sugioka A et al. |
FK 506 inhibits tolerance induction in mice liver transplantation. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808576
|
Porayko MK et al. |
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7679835
|
Iwasaki K et al. |
Pharmacokinetic study of FK 506 in the rat. |
1991 |
Transplant. Proc. |
pmid:1721268
|
Andersson J et al. |
FK 506 and cyclosporine inhibit antigen- or mitogen-induced monokine and lymphokine production in vitro. |
1992 |
Transplant. Proc. |
pmid:1371621
|
Takada S et al. |
HGF prevents tacrolimus (FK 506)-induced nephrotoxicity in SHR rats. |
1996 |
Transplant. Proc. |
pmid:8623236
|
Tsang WK et al. |
Efficacy and safety of mycophenolate mofetil in different dosages in Asian renal allograft recipients. |
2000 |
Transplant. Proc. |
pmid:11119921
|
Bond MMK et al. |
Cyclosporine Versus Tacrolimus: Which Calcineurin Inhibitor Has Influence on Cytomegalovirus Infection in Cardiac Transplantation? |
2018 |
Transplant. Proc. |
pmid:29661443
|
Chan KL et al. |
Porcine small bowel transplantation with FK506 as a single immunosuppressant. |
2001 |
Transplant. Proc. |
pmid:11406260
|
Santos L et al. |
New-onset diabetes after transplantation: drug-related risk factors. |
2012 |
Transplant. Proc. |
pmid:23146462
|
Asano T et al. |
Increased tacrolimus trough levels in association with severe diarrhea, a case report. |
2004 |
Transplant. Proc. |
pmid:15518758
|
Ichimaru N et al. |
Risk factors and incidence for lipid abnormalities in kidney transplant patients. |
2015 |
Transplant. Proc. |
pmid:25891708
|
Uchida H et al. |
Chronopharmacology of tacrolimus in rats: toxicity and efficacy in a mouse-to-rat intestinal transplant model and its pharmacokinetic profile. |
1999 |
Transplant. Proc. |
pmid:10578276
|
Wilusz M et al. |
Effect of immunosuppressive therapy on the serum fatty acids of phospholipids fraction in patients after heart transplantation. |
2014 |
Transplant. Proc. |
pmid:25380928
|
Huang CT et al. |
Higher Variability of Tacrolimus Trough Level Increases Risk of Acute Rejection in Kidney Transplant Recipients. |
|
Transplant. Proc. |
pmid:27569931
|
Choi SJ et al. |
Tacrolimus-induced apoptotic signal transduction pathway. |
2008 |
Transplant. Proc. |
pmid:18929848
|
Takara T et al. |
Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506. |
1994 |
Transplant. Proc. |
pmid:7518150
|
Jain A et al. |
Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. |
1992 |
Transplant. Proc. |
pmid:1376518
|
Watanabe K et al. |
Factors influencing long-term operational tolerance in dogs treated with fractionated lymphoid irradiation, donor bone marrow cell infusion and FK506. |
1995 |
Transplant. Proc. |
pmid:7533389
|
Borg AJ and Kumagai M |
FK 506 and xenogeneic human anti-porcine cellular reactivity. |
1991 |
Transplant. Proc. |
pmid:1721332
|
Junge G et al. |
Microchimerism in patients after orthotopic liver transplantation: a prognostic indicator? |
2002 |
Transplant. Proc. |
pmid:12176475
|
Kilian K et al. |
FK-506 (tacrolimus) therapy for an unusual SLE-like disease. |
1998 |
Transplant. Proc. |
pmid:9865322
|
Pohanka E et al. |
Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients. |
2005 |
Transplant. Proc. |
pmid:15919490
|
Marqués E et al. |
Development of lymphoproliferative disease after liver transplantation. |
2008 |
Transplant. Proc. |
pmid:19010169
|
Lemster B et al. |
Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium. |
1992 |
Transplant. Proc. |
pmid:1281576
|
Perego C et al. |
Orthotopic liver-small bowel transplantation in pigs: study of immunologic parameters during therapy with FK 506-based immunosuppressive regimens. |
1996 |
Transplant. Proc. |
pmid:8907908
|
Boggi U et al. |
Neoral versus prograf in simultaneous pancreas-kidney transplantation with portal venous drainage: three-year results of a single-center, open-label, prospective, randomized pilot study. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182772
|
Jensen CW et al. |
Pediatric renal transplantation under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721364
|
McCauley J et al. |
The question of FK 506 nephrotoxicity after liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1703344
|
Kociszewska-Najman B et al. |
Congenital Infections in Neonates of Women With Liver or Kidney Transplants. |
2016 |
Transplant. Proc. |
pmid:27496446
|
Moreno JM et al. |
Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantation. |
2003 |
Transplant. Proc. |
pmid:12962831
|
Shapiro R et al. |
A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176521
|
Nishimura Y et al. |
A trial to obtain donor-specific immunotolerance using a vascularized thymus allograft. |
1998 |
Transplant. Proc. |
pmid:9838684
|
Damotte D et al. |
Morphologic features of large bowel biopsies in combined small and large bowel transplantations could predict clinical rejection. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083252
|
Akutsu N et al. |
Two cases of calcineurin inhibitor-associated reversible posterior leukoencephalopathy syndrome in renal transplant recipients. |
2008 |
Transplant. Proc. |
pmid:18790253
|
Ota H et al. |
Intrathymic microchimerism predicts rejection response in allograft recipients. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123279
|
Kiuchi T et al. |
Experience of tacrolimus-based immunosuppression in living-related liver transplantation complicated with graft tuberculosis: interaction with rifampicin and side effects. |
1996 |
Transplant. Proc. |
pmid:8962229
|
Bunnapradist S and Takemoto SK |
Controlling treatment allocation bias in a registry analysis when comparing calcineurin inhibitors. |
2003 |
Transplant. Proc. |
pmid:14611971
|
Salizzoni M et al. |
Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation. |
2001 |
Transplant. Proc. |
pmid:11377521
|
El Haggan W et al. |
One year evolution of bone mineral density in kidney transplant recipients receiving tacrolimus versus cyclosporine. |
2002 |
Transplant. Proc. |
pmid:12176589
|
Falconer SJ et al. |
Conversion from twice-daily to once-daily tacrolimus in simultaneous pancreas-kidney transplant patients. |
2014 |
Transplant. Proc. |
pmid:24935313
|
Ishibashi M et al. |
Experimental study of tacrolimus immunosuppression on the mode of administration: efficacy of constant intravenous infusion avoiding C(max). |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266958
|
Gibelli NE et al. |
Sirolimus in pediatric liver transplantation: a single-center experience. |
2009 |
Transplant. Proc. |
pmid:19376384
|
Van Buren D et al. |
Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9723299
|
Kamar N et al. |
Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C. |
2004 |
Transplant. Proc. |
pmid:15621141
|
Fukuzawa M et al. |
Effect of donor-specific transfusion and FK 506 on small intestine allotransplantation. |
1991 |
Transplant. Proc. |
pmid:1721427
|
Park KM et al. |
Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine. |
1996 |
Transplant. Proc. |
pmid:8658863
|
Venkataramanan R et al. |
Biopharmaceutical aspects of FK-506. |
1987 |
Transplant. Proc. |
pmid:2445070
|
Demir T et al. |
Cancer Screening of Renal Transplant Patients Undergoing Long-Term Immunosuppressive Therapy. |
2015 |
Transplant. Proc. |
pmid:26093731
|
McCauley J et al. |
FK 506 in the management of transplant-related nephrotic syndrome and steroid-resistant nephrotic syndrome. |
1991 |
Transplant. Proc. |
pmid:1721459
|
Griffin AD et al. |
FK 506 in canine renal transplantation. |
1992 |
Transplant. Proc. |
pmid:1384209
|
Hesse CJ et al. |
Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12431679
|
Preston R et al. |
FK 506 as primary immunosuppressive therapy in renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9636493
|
Ericzon BG et al. |
Effect of FK 506 on glucose metabolism in the cynomolgus monkey: studies in pancreatic transplant recipients and nontransplanted animals. |
1991 |
Transplant. Proc. |
pmid:1703695
|
White SA et al. |
Effect of acute rejection on expression of fibrosis associated genes in renal transplant recipients. |
2000 |
Transplant. Proc. |
pmid:10700949
|